FOLLICULAR DENDRITIC CELLS AND HIV PATHOGENESIS

滤泡树突细胞和 HIV 发病机制

基本信息

  • 批准号:
    2887219
  • 负责人:
  • 金额:
    $ 21.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-07-15 至 2000-09-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (Adapted from investigator's abstract) Large amounts of HIV are trapped on follicular dendritic cells (FDC) in the germinal centers of secondary lymphoid tissues. throughout clinical latency when CD+4 T cells continually decline, these germinal centers with virus-laden FDC, highly activated, CD+4 T cells and a state of high cellular activation are the primary sites of active HIV replication. The investigators hypothesize that FDC play a major role in HIv pathogenesis by: (1) serving as a reservoir of infectious HIV; (2) potentiating both de novo infection of newly entering cells and of latently infected cells coming into the germinal center; and (3) by permitting infection in the presence of high levels of neutralizing antibody. They also hypothesize that FDC features that promote infection may be able to be inhibited. In support of the hypothesis, they have recently shown that FDC trapped HIV immune complexes are highly infectious and they have data suggesting that FDC maintain HIV infectivity even in the absence of viral replication. They also have evidence that FDC promote a significant increase in the amount of HIV infection in both newly and latently infected T cells. Lastly they have found that FDC permit infection even in the presence of a vast excess of neutralizing antibody. The investigators believe that their hypothesis is exciting and that an understanding of FDC contributions to HIV pathogenesis will be critical in designing intervention strategies that can attack this reservoir of infectious virus. Current strategies to stop viral replication do not target the FDC reservoir which remains until the cells are destroyed and the lymph node involutes prior to the onset of AIDS. thus an understanding of FDC contributions may allow them to successfully target this important cell and its viral reservoir.
描述:(改编自研究者的摘要)大量的艾滋病毒

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gregory F. Burton其他文献

Gregory F. Burton的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gregory F. Burton', 18)}}的其他基金

Follicular dendritic cell activation and HIV pathogenesis
滤泡树突状细胞激活和 HIV 发病机制
  • 批准号:
    8012521
  • 财政年份:
    2010
  • 资助金额:
    $ 21.38万
  • 项目类别:
FOLLICULAR DENDRITIC CELLS AND HIV PATHOGENESIS
滤泡树突细胞和 HIV 发病机制
  • 批准号:
    2442700
  • 财政年份:
    1996
  • 资助金额:
    $ 21.38万
  • 项目类别:
Follicular dendritic cells & HIV Pathogenesis
滤泡树突状细胞
  • 批准号:
    6409061
  • 财政年份:
    1996
  • 资助金额:
    $ 21.38万
  • 项目类别:
FOLLICULAR DENDRITIC CELLS & HIV PATHOGENESIS
滤泡树突状细胞
  • 批准号:
    6214687
  • 财政年份:
    1996
  • 资助金额:
    $ 21.38万
  • 项目类别:
Follicular dendritic cells & HIV Pathogenesis
滤泡树突状细胞
  • 批准号:
    6510501
  • 财政年份:
    1996
  • 资助金额:
    $ 21.38万
  • 项目类别:
FOLLICULAR DENDRITIC CELLS AND HIV PATHOGENESIS
滤泡树突细胞和 HIV 发病机制
  • 批准号:
    2076912
  • 财政年份:
    1996
  • 资助金额:
    $ 21.38万
  • 项目类别:
Follicular dendritic cells & HIV Pathogenesis
滤泡树突状细胞
  • 批准号:
    6631833
  • 财政年份:
    1996
  • 资助金额:
    $ 21.38万
  • 项目类别:
Follicular Dendritic Cells and HIV Pathogenesis
滤泡树突状细胞和 HIV 发病机制
  • 批准号:
    7073866
  • 财政年份:
    1996
  • 资助金额:
    $ 21.38万
  • 项目类别:
FOLLICULAR DENDRITIC CELLS AND HIV PATHOGENESIS
滤泡树突细胞和 HIV 发病机制
  • 批准号:
    2672780
  • 财政年份:
    1996
  • 资助金额:
    $ 21.38万
  • 项目类别:
SMALL INSTRUMENTATION GRANT
小型仪器补助金
  • 批准号:
    2073654
  • 财政年份:
    1994
  • 资助金额:
    $ 21.38万
  • 项目类别:

相似海外基金

Study on the mechanism of prolonged half-life of blood IgY by unique antibody receptor and its application to immune enhancement in birds
独特抗体受体延长血液IgY半衰期的机制研究及其在禽类免疫增强中的应用
  • 批准号:
    23H02361
  • 财政年份:
    2023
  • 资助金额:
    $ 21.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
  • 批准号:
    nhmrc : GNT1124162
  • 财政年份:
    2017
  • 资助金额:
    $ 21.38万
  • 项目类别:
    Early Career Fellowships
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
  • 批准号:
    nhmrc : 1124162
  • 财政年份:
    2017
  • 资助金额:
    $ 21.38万
  • 项目类别:
    Early Career Fellowships
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
  • 批准号:
    9300976
  • 财政年份:
    2015
  • 资助金额:
    $ 21.38万
  • 项目类别:
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
  • 批准号:
    9920805
  • 财政年份:
    2015
  • 资助金额:
    $ 21.38万
  • 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
  • 批准号:
    8900121
  • 财政年份:
    2012
  • 资助金额:
    $ 21.38万
  • 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
  • 批准号:
    8225814
  • 财政年份:
    2012
  • 资助金额:
    $ 21.38万
  • 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
  • 批准号:
    8699511
  • 财政年份:
    2012
  • 资助金额:
    $ 21.38万
  • 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
  • 批准号:
    8525355
  • 财政年份:
    2012
  • 资助金额:
    $ 21.38万
  • 项目类别:
Small Grants for Exploratory Research: Separation of Cells and Biological Macromolecules by Antibody Receptor Coated Magnetic Vesicles and Ferritin Conjugates
探索性研究小额资助:通过抗体受体包被的磁囊和铁蛋白缀合物分离细胞和生物大分子
  • 批准号:
    9115537
  • 财政年份:
    1991
  • 资助金额:
    $ 21.38万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了